451

Compound name
Catequentinib
Alt Name
Anlotinib
AL3818
AL-3818
Compound Image
Catequentinib.png
SMILES
CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC
MW
407.40
Brutto
C23H22FN3O3
InChI
InChI=1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3
InChI Key
KSMZEXLVHXZPEF-UHFFFAOYSA-N
Approval Jurisdiction
2018 China
Approved for clinical use
NSCLC
CAS
1058156-90-3
PubChem CID
25017411
Action
VEGFRs
Approved Drug List
1
Commercial Vendor
Advenchen Laboratories